A Phase III, randomized, controlled, non-inferiority trial of ceftaroline fosamil 600 mg every 8 h versus vancomycin plus aztreonam in patients with complicated skin and soft tissue infection with systemic inflammatory response or underlying comorbidities

Evaluation of the pharmacokinetics and safety of single and multiple ceftaroline fosamil infusions in healthy Chinese and Western subjects

(2015) Li Yang et al.   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Ceftaroline fosamil versus ceftriaxone for the treatment of Asian patients with community-acquired pneumonia: a randomised, controlled, double-blind, phase 3, non-inferiority with nested superiority trial

(2015) Nan Shan Zhong et al.   LANCET INFECTIOUS DISEASES

Ceftaroline activity tested against contemporary Latin American bacterial pathogens (2011)

(2014) Robert K. Flamm et al.   Brazilian Journal of Infectious Diseases

In vitro activity of ceftaroline tested against isolates from the Asia-Pacific region and South Africa (2011)

(2014) Robert K. Flamm et al.   Journal of Global Antimicrobial Resistance

Activity of ceftaroline and comparator agents tested against contemporary Gram-positive and -negative (2011) isolates collected in Europe, Turkey, and Israel

(2013) Mariana Castanheira et al.   JOURNAL OF CHEMOTHERAPY

Integrated safety summary of FOCUS 1 and FOCUS 2 trials: Phase III randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with community-acquired pneumonia

(2011) D. R. Rank et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Epidemiology and risk factors for drug allergy

(2010) Bernard Y-H. Thong et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Integrated Analysis of CANVAS 1 and 2: Phase 3, Multicenter, Randomized, Double‐Blind Studies to Evaluate the Safety and Efficacy of Ceftaroline versus Vancomycin plus Aztreonam in Complicated Skin and Skin‐Structure Infection

(2010) G. Ralph Corey et al.   CLINICAL INFECTIOUS DISEASES

CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections

(2010) M. H. Wilcox et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections

(2010) G. R. Corey et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Integrated safety summary of CANVAS 1 and 2 trials: Phase III, randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections

(2010) M. L. Corrado   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY